News releases
Showing 11 - 17 of 17 results
December 12, 2024
Leveraging insights from industry experts at Vizient and its subsidiary Kaufman Hall, the company today published its 2025 trends report, “Strategy is (finally) back in the driver’s seat”, providing ... read more
August 20, 2024
Vizient, Inc. offered comments to the Food and Drug Administration on biosimilar interchangeability... read more
April 23, 2024
The inaugural symposium brought together leading healthcare providers, payers and manufacturers of high-cost, ultra-specialty pharmaceuticals to discuss the promise the rapidly expanding market of ce... read more
August 23, 2022
The survey of hospital leaders and pharmacy professionals from Vizient member hospitals across the country found that biosimilars are gaining inclusion in hospital formularies, something long seen as... read more
January 26, 2022
The finding is reported in the Vizient Winter 2022 Pharmacy Market Outlook, which forecasts an overall 3.09% increase in drug prices for July 1, 2022 through June 30, 2023... read more
August 30, 2021
Vizient released an analysis which estimates U.S. hospitals are spending $310 million annually to manage additional work of white and brown bagging... read more
November 23, 2020
Vizient releases updated analysis showing ending the FDA's Unapproved Drugs Initiative could save hospitals between $7.52 billion and $26.59 billion... read more